Purchase Order N6817124P2033
Award Date
7/3/24
Potential Completion Date
9/27/24
Potential Value
$4.4K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $6,580.57 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Instrumentation Laboratory S.P.A., a global leader in specialized diagnostics. The contract is for the delivery of BLOOD BANK REAGENTS, which are likely used to support the blood typing and cross-matching capabilities of the U.S. military's medical readiness programs. Instrumentation Laboratory S.P.A. has a significant track record of providing advanced medical diagnostic equipment, such as GEM...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Instrumentation Laboratory S.P.A., a global leader in specialized diagnostics. The contract, valued at $4,894.33, is for the maintenance of an ACL 7000 device. Instrumentation Laboratory S.P.A. is a for-profit organization that has been registered to receive federal awards since 2003 and specializes in providing medical equipment, reagents, and...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a $4,970.47 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract provides Immucor's specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and critical blood banking operations within federal health networks and military treatment centers. Immucor has a...
This is a $33,303.25 firm fixed price delivery order awarded to Instrumentation Laboratory S.P.A., a global leader in specialized diagnostics, by the U.S. Department of the Navy Bureau of Medicine and Surgery. The order is for GEM PREMIER 5000 PAK (31D) devices, which are likely advanced blood gas analyzers used in military medical facilities. This delivery order is part of a larger $178,382.63 Indefinite Delivery Contract (IDC) that the Navy awarded to Instrumentation Laboratory S.P.A. on...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood...
This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract is for a base year plus four option years, with a ceiling value of $29,848.00, for the provision of blood bank reagents. The contract is issued under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and does not have a set-aside designation. Immucor is a key supplier of...
This is a firm-fixed price supply contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract, valued at $1,016,206.99, is for the delivery of consumable reagents used for blood typing, antibody screening, and identifying compatible blood products for transfusion. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods. The original...